By attending this webinar,
you will receive 7 from
Message from the
"For information on how this activity fits in the Royal College Maintenance of Certification (MOC) Program, please visit the Royal College’s website. For more personalized support, please contact the Royal College Services Centre (1-800-461-9598) or your local CPD Educator."
- In order to better understand where the new ANTIPSYCHOTIC treatment options fit in the pharmacological toolkit, we will review what treatments are currently available, including a rapid overview of conventional/typical agents and a deeper dive into atypical antipsychotics, including D2 partial agonists.
- Categorize and compare the unique characteristics of newer treatments and how they may be utilized in daily practice.
Review each newer treatment based on the expected clinical utilization, highlighting:
- mechanism of action
- route of administration (oral, sublingual, IM, long-acting injectable)
- typical dosage and titration schedule
- switching and combining
- common adverse events
- usual treatment population
Dr. McIntosh obtained an undergraduate degree in pharmacy before completing her medical school training, 2-years of a pediatric residency and then an adult psychiatry residency. She is a clinical assistant professor at the University of British Columbia and has a community psychiatry practice.
Dr. McIntosh is extensively involved in providing continuing medical education programs to colleagues nationally and internationally, with a focus on rational pharmacology and the neurobiology of mood and anxiety disorders and ADHD. Every year, she delivers more than 200 lectures, always coming back to an essential, central theme: we must strive to improve the quality of care and the treatment options available for people diagnosed with a mental illness.
Dr. McIntosh is the co-founder of SwitchRx, the online psychotropic switching tool for prescribers and pharmacists. She has her own continuing medical education program, PsychedUp, which was developed to encourage the appropriate, confident, rational prescribing of psychiatric medications. She has published blogs in Psychology Today and the Huffington Post and Op-Eds for newspapers focusing on mental health issues. She is also the founder of We Do Matter, which advocates more compassionate care for psychiatric patients and their families.
Dr. McIntosh’s new book, This is Depression: A comprehensive and compassionate guide for those who want to understand depression, was launched on October 10, 2019 and quickly became an Amazon Canada bestseller. It is written for those who have depression, for those who love someone who is depressed, and for anyone who wants to better understand the disorder.
Dr. Ric Procyshyn is a Clinical Professor in the Department of Psychiatry, UBC.
He also holds the position of clinical research psychopharmacologist at the BC Mental Health and Substance Use Services Research Institute and acts as a consultant for the BC Psychosis Program.
Ric has authored over 180 articles in peer-reviewed journals; is the principal editor of the Clinical Handbook of Psychotropic Drugs; and is the co-developer of the SwitchRx website.
Dr. Procyshyn enjoys teaching and has been awarded several teaching awards from the Faculty of Pharmaceutical Sciences, University of British Columbia.